|
|
|
INSULIN SECRETION PATHWAY (PW:0000674)
DescriptionIn
response to elevated blood glucose, the pancreatic beta cells of the islets of
Langerhans secrete insulin. Processed insulin is stored in secretory granules along
with other low molecular weight molecules and metals. Glucose levels couple to
changes in membrane potential to regulate secretion of insulin-granules. Beta
cells express a high capacity glucose transporter and the G6P insensitive
glucokinase. Fast uptake of glucose into the cell and rapid phosphorylation are
followed by its oxidative metabolism. The resulting Increase in ATP/ADP ratio
triggers closure of the ATP-sensitive potassium channel (K ATP) leading
to membrane depolarization and opening of voltage-gated calcium channels (VDCC).
Rise in calcium concentration induces fusion of insulin-granules with the
plasma membrane and SNARE-mediated exocytosis. Exocytosis of insulin-granules
is biphasic: an initial rapid release is followed by a slower but sustained
second release. The 'triggering' first phase involves granules at or near the
plasma membrane - the 'readily releasable pool' (RRP).The mobilization of
granules from a 'storage-granule pool' (SGP) along with those already docked
underlies the second 'amplifying' phase, largely independent of K ATP
channels. The membrane depolarization that opens VDCC also activates the
voltage dependent potassium channels (Kcn) leading to re-polarization of the
membrane and closure of VDCC. The t-SNARE Snap25 and Stx1a co-localize and/or
interact with all channels to potentiate or modulate their activity. Shown is
Snap25 which has been reported to bind to and inhibit Kcn. During calcium
triggered membrane fusion, the minimal SNARE complex of Snap25, Stx1a and
v-SNARE Vamp2 changes from trans to cis configuration. Proposed calcium
sensors include members of the Syt family; Munc proteins regulate aspects of complex
assembly. Monomeric G protein Rho/Rac/Cdc42 and Rab mediated pathways regulate
cytoskeletal rearrangements, important for vesicular transport, and vesicular
trafficking, respectively. Cdc42 and Rac1, Rab27a and Rab3a are co-localized
with insulin-granules of one or both phases, their exact role under
investigation. The second phase of insulin secretion is less well understood; metabolic
coupling factors resulting from cycling of pyruvate in the course of glucose
metabolism have been suggested to play a role. NADPH, one such factor, can
inhibit Kcn activity. Identification of all components and regulators of the
pathway are subjects of intense research. The importance of delineating the
molecular details of insulin secretion pathway is heightened by the fact that
both release phases are impaired in type II diabetes. To see the ontology report for annotations, GViewer and
download, click here
[click to see the ontology
report for associated GO term - GO:0030073 and related entry at Reactome - REACT_18325.2]...(less)
|
Pathway Diagram:
|
|
|
Genes in Pathway:
insulin secretion pathway
|
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
TAS |
1 |
96,622,574 |
96,703,723 |
RGD:2311063 |
RGD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
|
TAS |
19 |
25,188,170 |
25,424,495 |
RGD:2311105 |
RGD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
|
TAS |
4 |
154,895,691 |
155,517,389 |
RGD:2311105 |
RGD |
| G |
Cacna1d |
calcium channel, voltage-dependent, L type, alpha 1D subunit |
|
|
TAS |
16 |
5,383,259 |
5,703,361 |
RGD:2311105 |
RGD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
|
ISS |
5 |
156,106,123 |
156,143,040 |
RGD:2311087 |
RGD |
| G |
Gck |
glucokinase |
|
|
TAS |
14 |
86,572,518 |
86,587,723 |
RGD:2311061 |
RGD |
| G |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
|
|
TAS |
3 |
158,250,001 |
158,345,927 |
RGD:2311121 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
TAS |
1 |
96,614,960 |
96,617,993 |
RGD:2311063 |
RGD |
| G |
Rab27a |
RAB27A, member RAS oncogene family |
|
|
ISS |
8 |
77,798,830 |
77,861,090 |
RGD:2311087 |
RGD |
| G |
Rab3a |
RAB3A, member RAS oncogene family |
|
|
ISS |
16 |
19,189,765 |
19,193,874 |
RGD:2311087 |
RGD |
| G |
Slc2a2 |
solute carrier family 2 (facilitated glucose transporter), member 2 |
|
|
TAS |
2 |
116,036,501 |
116,065,834 |
RGD:2311061 |
RGD |
| G |
Snap25 |
synaptosomal-associated protein 25 |
|
|
TAS |
3 |
124,806,637 |
124,894,653 |
RGD:2311121 |
RGD |
| G |
Stx1a |
syntaxin 1A (brain) |
|
|
ISS |
12 |
22,737,112 |
22,765,064 |
RGD:2311087 |
RGD |
| G |
Stxbp1 |
syntaxin binding protein 1 |
|
|
ISS |
3 |
11,762,105 |
11,825,531 |
RGD:2311087 |
RGD |
| G |
Syt7 |
synaptotagmin VII |
|
|
IMP |
1 |
212,876,675 |
212,935,373 |
RGD:2311143 |
RGD |
| G |
Syt7 |
synaptotagmin VII |
|
|
TAS |
1 |
212,876,675 |
212,935,373 |
RGD:2311148 |
RGD |
| G |
Syt7_v1 |
synaptotagmin 7, variant 1 |
|
|
IMP |
|
|
|
RGD:2311143 |
RGD |
| G |
Syt9 |
synaptotagmin IX |
|
|
TAS |
1 |
164,722,168 |
164,928,937 |
RGD:2311148 |
RGD |
| G |
Syt9 |
synaptotagmin IX |
|
|
IMP |
1 |
164,722,168 |
164,928,937 |
RGD:2311147 |
RGD |
| G |
Unc13a |
unc-13 homolog A (C. elegans) |
|
|
ISS |
16 |
18,827,405 |
18,872,461 |
RGD:2311087 |
RGD |
| G |
Vamp2 |
vesicle-associated membrane protein 2 |
|
|
ISS |
10 |
55,848,264 |
55,852,132 |
RGD:2311087 |
RGD |
altered insulin secretion pathway
|
| G |
Abcc8 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 8 |
|
|
ISS |
1 |
96,622,574 |
96,703,723 |
RGD:2313628 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:2313628 |
RGD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
|
ISS |
1 |
96,614,960 |
96,617,993 |
RGD:2313610 |
RGD |
|
|
|
Pathway Gene Annotations |
|
Disease Annotations Associated with Genes in the insulin secretion pathway
|
|
|
|
| Abcc8 | Brain Edema , Diabetes Mellitus , Diabetes Mellitus, Permanent Neonatal , Diabetes Mellitus, Transient Neonatal, 2 , Diabetes Mellitus, Type 2 , Endotoxemia , Hyperinsulinemic hypoglycemia, familial, 1 , Hyperinsulinism , Hyperplasia , Hypertension , Hypoglycemia , Hypoglycemia, leucine-induced , Myocardial Reperfusion Injury , Necrosis , Parkinsonian Disorders , Seizures , Stroke | | Cacna1a | Epilepsy , Episodic ataxia with nystagmus , MIGRAINE, FAMILIAL HEMIPLEGIC, 1 , Spinocerebellar Ataxias | | Cacna1c | Arrhythmias, Cardiac , Brugada Syndrome , Brugada Syndrome 3 , Death, Sudden , Syncope , Timothy syndrome | | Cacna1d | Deafness , Dyskinesia, Drug-Induced , Memory Disorders , Sciatic Neuropathy | | Cdc42 | Alzheimer Disease , Arthritis, Experimental , Bipolar Disorder , Epilepsy, Temporal Lobe , Fibrosarcoma , Reperfusion Injury , Rhinitis , Spinal Cord Injuries | | Gck | Coronary Artery Disease , Diabetes Mellitus , Diabetes Mellitus, Experimental , Diabetes Mellitus, Permanent Neonatal , Diabetes Mellitus, Type 2 , Diabetes, Gestational , Hyperinsulinemic hypoglycemia, familial, 3 , Hyperinsulinism , Hypertension , Hypoglycemia , Maturity-Onset Diabetes of the Young, Type 2 | |
| Kcnj11 | Diabetes Mellitus , Diabetes Mellitus, Permanent Neonatal , Diabetes Mellitus, Transient Neonatal, 3 , Diabetes Mellitus, Type 2 , Hyperinsulinemic hypoglycemia, familial, 2 , Hyperinsulinism , Hypertension , Parkinsonian Disorders , Prediabetic State , Seizures | | Rab27a | Congenital Abnormalities , Griscelli syndrome type 2 , Histiocytosis, Non-Langerhans-Cell , Hypopigmentation | |
| Slc2a2 | Carcinoma, Pancreatic Ductal , Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Fanconi Syndrome , Fanconi-Bickel Syndrome , Gastrinoma , Glucagonoma , Glycogen Storage Disease , Insulinoma , Neural Tube Defects | | Snap25 | Down Syndrome | | Stx1a | Creutzfeldt-Jakob Syndrome , Hirschsprung Disease | | Stxbp1 | Epileptic Encephalopathy, Early Infantile, 4 | |
|
|
| Unc13a | Amyotrophic Lateral Sclerosis , Fetal Growth Retardation | |
|
| Amyotrophic Lateral Sclerosis | Unc13a | | Brugada Syndrome | Cacna1c | | Fanconi Syndrome | Slc2a2 | | Diabetes Mellitus | Gck , Abcc8 , Kcnj11 | | Epilepsy | Cacna1a | | Deafness | Cacna1d | | Fetal Growth Retardation | Unc13a | | Seizures | Abcc8 , Kcnj11 | | Episodic ataxia with nystagmus | Cacna1a | | Diabetes Mellitus, Type 2 | Gck , Slc2a2 , Abcc8 , Kcnj11 | | Congenital Abnormalities | Rab27a | | Neural Tube Defects | Slc2a2 | | Hypoglycemia | Abcc8 , Gck | | Hirschsprung Disease | Stx1a | | Hyperplasia | Abcc8 | | Hypopigmentation | Rab27a | | Death, Sudden | Cacna1c | | Rhinitis | Cdc42 | | Brain Edema | Abcc8 | | Spinocerebellar Ataxias | Cacna1a | | Alzheimer Disease | Cdc42 | | Arrhythmias, Cardiac | Cacna1c | | Glucagonoma | Slc2a2 | | Epilepsy, Temporal Lobe | Cdc42 | | Timothy syndrome | Cacna1c | | Hypertension | Gck , Abcc8 , Kcnj11 | | Hypoglycemia, leucine-induced | Abcc8 | | Parkinsonian Disorders | Abcc8 , Kcnj11 | | Griscelli syndrome type 2 | Rab27a | | Syncope | Cacna1c | | Glycogen Storage Disease | Slc2a2 | | Hyperinsulinemic hypoglycemia, familial, 1 | Abcc8 | | Hyperinsulinemic hypoglycemia, familial, 2 | Kcnj11 | | Hyperinsulinemic hypoglycemia, familial, 3 | Gck | | Hyperinsulinism | Gck , Abcc8 , Kcnj11 | | Creutzfeldt-Jakob Syndrome | Stx1a | | Memory Disorders | Cacna1d | | Arthritis, Experimental | Cdc42 | | Bipolar Disorder | Cdc42 | | Coronary Artery Disease | Gck | | Necrosis | Abcc8 | | Diabetes Mellitus, Experimental | Gck , Slc2a2 | | Down Syndrome | Snap25 | | Dyskinesia, Drug-Induced | Cacna1d | | Diabetes, Gestational | Gck | | Fibrosarcoma | Cdc42 | | Insulinoma | Slc2a2 | | Histiocytosis, Non-Langerhans-Cell | Rab27a | | Prediabetic State | Kcnj11 | | Sciatic Neuropathy | Cacna1d | | Spinal Cord Injuries | Cdc42 | | Gastrinoma | Slc2a2 | | Reperfusion Injury | Cdc42 | | Myocardial Reperfusion Injury | Abcc8 | | Endotoxemia | Abcc8 | | Stroke | Abcc8 | | Carcinoma, Pancreatic Ductal | Slc2a2 | | MIGRAINE, FAMILIAL HEMIPLEGIC, 1 | Cacna1a | | Fanconi-Bickel Syndrome | Slc2a2 | | Diabetes Mellitus, Permanent Neonatal | Gck , Abcc8 , Kcnj11 | | Diabetes Mellitus, Transient Neonatal, 2 | Abcc8 | | Maturity-Onset Diabetes of the Young, Type 2 | Gck | | Diabetes Mellitus, Transient Neonatal, 3 | Kcnj11 | | Epileptic Encephalopathy, Early Infantile, 4 | Stxbp1 | | Brugada Syndrome 3 | Cacna1c | |
|